Bustamante Juan J, Grigorian Alexei L, Muñoz Jesus, Aguilar Roberto M, Treviño Lisa R, Martinez Andrew O, Haro Luis S
Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas 78363, USA.
Growth Horm IGF Res. 2010 Aug;20(4):298-304. doi: 10.1016/j.ghir.2010.03.007. Epub 2010 May 15.
Human growth hormone (hGH) is a complex mixture of molecular isoforms. Gaps in our knowledge exist regarding the structures and biological significances of the uncharacterized hGH molecular variants. Mercaptoethanol-resistant 45-kDa human growth hormone (MER-45 kDa hGH) is an extraordinarily stable disulfide-linked hGH homodimer whose biological significance is unknown.
To elucidate the pharmacokinetic abilities of dimeric MER-45-kDa hGH to bind to GH and prolactin (PRL) receptors and to elucidate its abilities to stimulate cell proliferation in lactogen-induced and somatogen-induced in vitro cell proliferation bioassays.
The binding of MER-45-kDa hGH to GH and PRL receptors was tested in radioreceptor assays (RRAs). Competitive displacements of [(125)I]-bovine GH from bovine liver membranes, [(125)I]-ovine PRL from lactating rabbit mammary gland membranes and [(125)I]-hGH from human IM-9 lymphocytes by unlabelled GHs, PRLs or dimeric MER-45-kDa hGH were evaluated. The abilities of dimeric MER-45-kDa hGH to stimulate proliferation of lactogen-responsive Nb2 lymphoma cells and to stimulate proliferation of somatogen-responsive T47-D human breast cancer cells were assessed by incubation of cells with GHs or PRLs and subsequently measuring growth using the MTS cell proliferation assay.
Dimeric MER-45-kDa hGH, compared to monomeric hGH, had reduced binding affinities to both GH and prolactin receptors. In a bovine liver GH radioreceptor assay its ED(50) (197.5 pM) was 40.8% that of monomeric hGH. In a human IM-9 lymphocyte hGH RRA its ED(50) (2.96 nM) was 26.2% that of monomeric hGH. In a lactating rabbit mammary gland prolactin RRA its ED(50) (3.56 nM) was 16.8% that of a monomeric hGH. Dimeric MER-45-kDa hGH, compared to monomeric hGH, had a diminished capacity to stimulate proliferation of cells in vitro. In a dose-response relationship assessing proliferation of Nb2 lymphoma cells its ED(50) (191 pM) was 18.0% that of monomeric hGH. While monomeric hGH stimulated a 2.2-fold proliferation of T47-D human breast cancer cells above vehicle control, dimeric MER-45-kDa hGH was unable to stimulate the cells to proliferate and slightly inhibited their proliferation to 77.6% that of control.
The topological arrangement of monomeric hGHs to form an unusually stable disulfide-linked dimer markedly diminishes hGH's binding affinities to both GH and PRL receptors and also drastically attenuates its ability to stimulate proliferation of cells in vitro.
人生长激素(hGH)是分子异构体的复杂混合物。关于未表征的hGH分子变体的结构和生物学意义,我们的认识还存在空白。巯基乙醇抗性45 kDa人生长激素(MER - 45 kDa hGH)是一种极其稳定的二硫键连接的hGH同二聚体,其生物学意义尚不清楚。
阐明二聚体MER - 45 kDa hGH与生长激素(GH)和催乳素(PRL)受体结合的药代动力学能力,并阐明其在催乳素诱导和生长激素诱导的体外细胞增殖生物测定中刺激细胞增殖的能力。
在放射受体分析(RRA)中测试MER - 45 kDa hGH与GH和PRL受体的结合。通过未标记的GH、PRL或二聚体MER - 45 kDa hGH评估其对牛肝膜中[(125)I]-牛GH、泌乳兔乳腺膜中[(125)I]-羊PRL和人IM - 9淋巴细胞中[(125)I]-hGH的竞争性置换。通过将细胞与GH或PRL孵育,随后使用MTS细胞增殖测定法测量生长,评估二聚体MER - 45 kDa hGH刺激催乳素反应性Nb2淋巴瘤细胞增殖和生长激素反应性T47 - D人乳腺癌细胞增殖的能力。
与单体hGH相比,二聚体MER - 45 kDa hGH与GH和催乳素受体的结合亲和力降低。在牛肝GH放射受体分析中,其半数有效剂量(ED(50))(197.5 pM)为单体hGH的40.8%。在人IM - 9淋巴细胞hGH RRA中,其ED(50)(2.96 nM)为单体hGH的26.2%。在泌乳兔乳腺催乳素RRA中,其ED(50)(3.56 nM)为单体hGH的16.8%。与单体hGH相比,二聚体MER - 45 kDa hGH在体外刺激细胞增殖的能力减弱。在评估Nb2淋巴瘤细胞增殖的剂量反应关系中,其ED(50)(191 pM)为单体hGH的18.0%。虽然单体hGH刺激T47 - D人乳腺癌细胞增殖比载体对照高2.2倍,但二聚体MER - 45 kDa hGH无法刺激细胞增殖,反而略微抑制其增殖至对照的77.6%。
单体hGH形成异常稳定的二硫键连接二聚体的拓扑排列显著降低了hGH与GH和PRL受体的结合亲和力,也极大地减弱了其体外刺激细胞增殖的能力。